NATALIZUMAB
natalizumab 150 mg/mL injection, 2 x 1 mL syringes
NATALIZUMAB (13820J)
13820J
Manner of administration:Injection
Restriction (Streamlined authority code: 13625)
Indication: Clinically definite relapsing-remitting multiple sclerosis
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 2 | # of repeats: 5 | DPMQ: $637.97 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Tysabri | |||||
